Author

Mohamad Abdel Moaty Samra

National Cancer Institute, Cairo University - Cited by 535 - Professor of Oncology and Hematology

Biography

Mohamad Abdel Moaty Samra  is a well-known researcher working in Department of Hematology and BMT, National Cancer Institute, Cairo University, Egypt and has extended valuable service for many years and has been a recipient of many awards and grants.
Title
Cited by
Year
The role of inflammatory indices in the outcome of COVID-19 cancer patients
HA Nooh, MS Abdellateif, L Refaat, EZ Kandeel, A Bayoumi, M Samra, ...Medical Oncology 39, 1-14, 2022202
18
2022
Could COVID-19 induce remission of acute leukemia?
EZ Kandeel, L Refaat, R Abdel-Fatah, M Samra, A Bayoumi, ...Hematology 26 (1), 870-873, 2021202
16
2021
Tracing leukemia stem cells and their influence on clinical course of adult acute myeloid leukemia
EZ Kandeel, N El Sharkawy, M Hanafi, M Samra, A KamelClinical Lymphoma Myeloma and Leukemia 20 (6), 383-393, 2020202
15
2020
Hematopoietic stem cell transplantation in Egypt: challenges and opportunities
HK Mahmoud, GM Fathy, A Elhaddad, OA Fahmy, M Abdel-Mooti, ...Mediterranean journal of hematology and infectious diseases 12 (1), 2020202
13
2020
The role of circulating tumor cells in metastatic breast cancer: prognostic and predictive value
AA Bahnassy, MM Saber, MG Mahmoud, MS Abdellateif, ...Molecular biology reports 45, 2025-2035, 2018201
11
2018
The potential association of CMV-specific CD8+ T lymphocyte reconstitution with the risk of CMV reactivation and persistency in post allogeneic stem cell transplant patients
AA Shams EL-Din, NA El-Desoukey, DG Amin Tawadrous, ...Hematology 23 (8), 463-46, 2018201
9
2018
Pf701 assessment of eltrombopag in patients with chronic immune thrombocytopenia under routine clinical practice in the middle east, Turkey, Asia, and Australia
R Wong, I Yavasoglu, MAD Yassin, P Tarkun, SS Yoon, MA Samra, ...HemaSphere 3 (S1), 305, 2019201
8
2019
MPN10 score and survival of molecularly annotated myeloproliferative neoplasm patients
YH ElNahass, HK Mahmoud, MM Mattar, OA Fahmy, MA Samra, ...Leukemia & Lymphoma 9 (4), 844-84, 2018201
5
2018
Polymorphisms of xeroderma pigmentosum genes (XPC, XPD, and XPG) and susceptibility to acute leukemia among a sample of Egyptian patients
IR ElMahgoub, HM Gouda, MA Samra, IAM Shaheen, AH ElMaraashlyJournal of Hematopathology 10, 3-7, 2017201
4
2017
IL12 and IFNγ secretion by donor mononuclear cells in response to host antigens may predict acute GVHD after HSCT
AM Kamel, NM Elsharkawy, EK Abdelfattah, R Abdelfattah, MA Samra, ...Immunobiology 22 (5), 659-665, 2019201
4
2019
Poor outcome of CRLF2 rearranged Philadelphia negative acute lymphoblastic leukemia adults patients
YH Elnahass, OA Fahmy, MAM Samra, FA Elrefaey, MT Bokhary, ...Blood, The Journal of the American Society of Hematology 132 (Supplement 1 …, 2018201
4
2018
Leukemia Stem Cell Frequency at Diagnosis Correlates With Measurable/Minimal Residual Disease and Impacts Survival in Adult Acute Myeloid Leukemia
AM Kamel, NM Elsharkawy, EZ Kandeel, M Hanafi, M Samra, RA OsmanFrontiers in Oncology 12, 86768, 2022202
4
2022
MPL W515 L/K mutations in myeloproliferative neoplasms
S Eldeweny, H Ibrahim, G Elsayed, M SamraEgyptian Journal of Medical Human Genetics 20 (1), 1-7, 2019201
3
2019
Prognostic and therapeutic value of day 14 bone marrow aspiration in adult acute myeloid leukemia patients
MM El Gammal, HM Owaidat, RA Rashed, RA Fatah, MA SamraClinical Lymphoma Myeloma and Leukemia 19 (7), e406-e41, 2019201
3
2019
Imatinib Generic in Newly Diagnosed Patients with Chronic Myeloid Leukemia in Chronic Phase: Egyptian National Cancer Institute Experience
M Maher, M Samra, R Abdelfatah, M ElGammal, H KamelClinical Lymphoma, Myeloma and Leukemia 19, S96-S97, 01901
2
2019
The use of post-transplantation cyclophosphamide in peripheral blood HLA-matched stem cell transplantation as graft-versus-host disease prophylaxis in patients with malignant …
HK Mahmoud, GM Fathy, A Elhaddad, OA Fahmy, M Abdel-Mooti, ...Clinical Lymphoma Myeloma and Leukemia 0 (10), 677-684, 000
2
2020
A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients
GH Elsisi, JL Carapinha, R Afify, MA Elmoty, M KhalafJournal of Medical Economics 3 (10), 1168-1175, 000
2
2020
Predictive value of the proliferation marker Ki-67 in patients with acute leukemia undergoing hematopoietic stem cell transplantation
H Gadallah, H Hegab, W Elsalakawy, MA Samra, BAT Farweez, AE SaadThe Egyptian Journal of Haematology 43 (4), , 01801
2
2018
Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern …
G AlDawsari, A Elhaddad, R El Fakih, T Ben Othman, P Ahmed, ...Bone Marrow Transplantation 55 (7), 485-490, 2020202
1
2020
Outcome of core binding factor acute myeloid leukemia by receptor tyrosine kinase mutation
AA Alnagar, AA Mahmoud, MMEL Gammal, N Hamdy, MA SamraClinical Lymphoma Myeloma and Leukemia 20 (7), 459-467, 2020202
1
2020

Referred From: https://scholar.google.com/citations?user=jz1olZkAAAAJ&hl=en

Cited by
Citations 535
h-index 14
i10-index 18
Recommended Journals
Open Access Journals